Skip to main content
. 2015 Mar 3;2015:809640. doi: 10.1155/2015/809640

Figure 3.

Figure 3

(a) Focal VMT. The arrow points to the ellipsoid zone. (b) Release of VMT after injection of ocriplasmin. A severe disruption in the ellipsoid zone is shown (by courtesy of Dr. Peter K. Kaiser, Cleveland Clinic, Cleveland, OH, USA).